Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul 12;13(1):11266.
doi: 10.1038/s41598-023-38221-7.

Impact of diabesity phenotype on cardiovascular diseases, major cardiovascular events and all-cause mortality

Affiliations

Impact of diabesity phenotype on cardiovascular diseases, major cardiovascular events and all-cause mortality

Kamran Mehrabani-Zeinabad et al. Sci Rep. .

Abstract

To investigate the longitudinal association of different phenotypes of diabetes and obesity with the incidence of cardiovascular disease (CVD), CVD- and all-cause mortality. A total of 5432 adults, aged ≥ 35 years and free of CVD were included in this cohort study. Diabesity phenotypes were defined in six categories based on the presence of diabetes (normal (NG), prediabetes and diabetes) and obesity (obese, non-obese). Fasting blood sugar, 2-h post prandial glucose, or using anti-diabetic medicines were used to define diabetes, and body mass index and waist circumference were used to define obesity. Cox proportional hazards models were used to estimate hazard ratios (HRs) for incident CVD, CVD- and all-cause mortality across these categories. After a median follow-up of 11.25 years, 819 CVD cases, 181 CVD deaths and 488 all-cause deaths occurred. In multivariable-adjusted models and irrespective of obesity definition, the phenotypes of normal glucose-obese, prediabetes-obese and pre-diabetes-non obese were not associated with CVD incidence in comparison with NG-non obese phenotype, however, the phenotypes of diabesity, either defined by general or abdominal obesity, were associated with increased risk of incident CVD events (HR = 1.42, 95% CI 1.01, 1.99, and HR = 1.46, 95% CI 1.07, 1.98, respectively). These findings were sex-specific and only in men with a phenotype of abdominal obesity-diabetes, a positive link was observed for CVD incidence (HR = 1.60, 95% CI 1.01, 2.52). No significant association was found between diabesity and death from CVD or all causes. Diabesity is a predictor of CVD and stroke incidence, but not CVD or all-cause mortality, among Iranians. This association is more pronounced amongst men than women.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
HRs (95% CIs) of adjusted model for CVD events, CVD mortality and all-cause mortality according to the diabesity phenotypes. Values are adjusted for age, SBP, TG, sex, smoking status, history of heart disease, history of high blood pressure and history of diabetes.
Figure 2
Figure 2
Sex-stratified HRs (95% CIs) of adjusted model for cardiovascular events, cardiovascular mortality and all-cause mortality according to the diabesity phenotypes. Values are adjusted for age, SBP, TG, smoking status, history of heart disease, history of high blood pressure and history of diabetes.
Figure 3
Figure 3
HRs (95% CIs) of adjusted model for various cardiovascular events according to the diabesity phenotypes. Values are adjusted for age, SBP, TG, sex, smoking status, history of heart disease, history of high blood pressure and history of diabetes.
Figure 4
Figure 4
Sex-stratified HRs (95% CIs) of adjusted model for various cardiovascular events according to the diabesity phenotypes. Values are adjusted for age, SBP, TG, sex, smoking status, history of heart disease, history of high blood pressure and history of diabetes.

Similar articles

Cited by

References

    1. Sun H, et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res. Clin. Pract. 2022;183:109119. doi: 10.1016/j.diabres.2021.109119. - DOI - PMC - PubMed
    1. Pourfarzi F, et al. Prevalence of overweight and obesity in Iranian population: A population-based study in northwestern of Iran. J. Public Health Res. 2021 doi: 10.4081/jphr.2021.2475. - DOI - PMC - PubMed
    1. Khamseh ME, et al. Nationwide prevalence of diabetes and prediabetes and associated risk factors among Iranian adults: Analysis of data from PERSIAN cohort study. Diabetes Ther. 2021;12(11):2921–2938. doi: 10.1007/s13300-021-01152-5. - DOI - PMC - PubMed
    1. World Health Organization. Obesity and overweight. Updated June 9, 2021. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight. Accessed 7 December 2021.
    1. Bakhshi E, et al. Obesity and related factors in Iran: The STEPS Survey, 2011. Iran. Red Crescent Med. J. 2015;17(6):e22479. doi: 10.5812/ircmj.17(6)2015.22479. - DOI - PMC - PubMed

Publication types